Extranodal NK-T-cell lymphoma risk factors

Jump to navigation Jump to search

Extranodal NK-T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Extranodal NK-T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Xray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Extranodal NK-T-cell lymphoma risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Extranodal NK-T-cell lymphoma risk factors

CDC on Extranodal NK-T-cell lymphoma risk factors

Extranodal NK-T-cell lymphoma risk factors in the news

Blogs on Extranodal NK-T-cell lymphoma risk factors

Risk calculators and risk factors for Extranodal NK-T-cell lymphoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

There is a strong association between with extranodal NK/T-cell lymphoma and EBV virus.There is a strong assosiation between Extranodal NK/T-cell lymphoma andFas(Po-1/CD95) mutations.

Risk Factors

  • There is a strong association between with extranodal NK/T-cell lymphoma and EBV virus.[1]
  • Studies revealed that there is a constant assosiation between NK/T-cell lymphoma with EBV in the world.[2][3][4]
  • There is a strong assosiation between Extranodal NK/T-cell lymphoma andFas(Po-1/CD95) mutations.[5]

References

  1. Ng SB, Khoury JD (2009). "Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist". Adv Anat Pathol. 16 (1): 40–55. doi:10.1097/PAP.0b013e3181916029. PMID 19098466.
  2. Kanavaros P, Lescs MC, Brière J, Divine M, Galateau F, Joab I; et al. (1993). "Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus". Blood. 81 (10): 2688–95. PMID 8387835.
  3. Mishima, Kenji; Horiuchi, Keisuke; Kojya, Shizuo; Takahashi, Hiroomi; Ohsawa, Masahiko; Aozasa, Katsuyuki (1994). "Epstein-barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from china and japan". Cancer. 73 (12): 3041–3046. doi:10.1002/1097-0142(19940615)73:12<3041::AID-CNCR2820731224>3.0.CO;2-K. ISSN 0008-543X.
  4. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F; et al. (1990). "Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma". Lancet. 335 (8682): 128–30. doi:10.1016/0140-6736(90)90002-m. PMID 1967431.
  5. Suda T, Takahashi T, Golstein P, Nagata S (1993). "Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family". Cell. 75 (6): 1169–78. doi:10.1016/0092-8674(93)90326-l. PMID 7505205.


Template:WikiDoc Sources